World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
27841
World Ranking
14554
National Ranking
7366

Eric M. Horwitz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Eric M. Horwitz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 530 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Eric M. Horwitz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Eric M. Horwitz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Eric M. Horwitz is affiliated with the Fox Chase Cancer Center in the United States. Their research focuses primarily on medicine, with significant contributions in pulmonary and respiratory medicine, radiation, surgery, radiology, nuclear medicine and imaging, as well as economics and econometrics.

Their main research topics emphasize prostate cancer treatment and research, prostate cancer diagnosis and treatment, and advanced radiotherapy techniques. Additional areas of study include health systems, economic evaluations, quality of life, cancer, lipids, and metabolism, radiomics and machine learning in medical imaging, and bladder and urothelial cancer treatments.

Frequent coauthors in their work include:

  • J.K. Wong
  • Brian J. Davis
  • M.A. Hallman
  • Juanita Crook
  • Phuoc T. Tran

Eric M. Horwitz has frequently published in the following venues:

  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • Brachytherapy
  • The Journal of Urology
  • European Urology

Recent notable papers include:

  • "NCCN Guidelines Insights: Prostate Cancer, Version 1.2021," 2021, Journal of the National Comprehensive Cancer Network
  • "A War on Two Fronts: Cancer Care in the Time of COVID-19," 2020, Annals of Internal Medicine
  • "Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management," 2022, The Journal of Urology
  • "Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up," 2022, The Journal of Urology
  • "Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate," 2020, JAMA Oncology

Best Publications

  • Prostate cancer. Clinical practice guidelines in oncology.

    James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby

  • Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    James L. Mohler;Emmanuel S. Antonarakis;Andrew J. Armstrong;Anthony V. D'Amico

  • Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

    Gerald E. Hanks;Thomas F. Pajak;Arthur Porter;David Grignon

  • Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

    Eric M. Horwitz;Kyounghwa Bae;Gerald E. Hanks;Arthur Porter

  • Prostate Cancer, Version 1.2016

    James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Anthony Victor D'Amico

  • Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

    J. M Crook;C. J O'Callaghan;G Duncan;D. P Dearnaley

  • Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

    Michael J. Zelefsky;Deborah A. Kuban;Larry B. Levy;Louis Potters

  • Causes of death among cancer patients

    Nicholas G. Zaorsky;T. M. Churilla;B. L. Egleston;S. G. Fisher

  • American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

    Brian J. Davis;Eric M. Horwitz;W. Robert Lee;Juanita M. Crook

  • Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

    Alan Pollack;Gail Walker;Eric M. Horwitz;Robert Price

  • A War on Two Fronts: Cancer Care in the Time of COVID-19.

    Alexander Kutikov;David S. Weinberg;Martin J. Edelman;Eric M. Horwitz

  • Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911

    Corey J. Langer;Jonathan Harris;Eric M. Horwitz;Nicos Nicolaou

  • Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology

    James L. Mohler;Philip W. Kantoff;Andrew J. Armstrong;Robert R. Bahnson

  • Prostate cancer, version 1.2021: Featured updates to the nccn guidelines

    Edward Schaeffer;Sandy Srinivas;Emmanuel S. Antonarakis;Andrew J. Armstrong

  • Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.

    Amar U. Kishan;Ryan R. Cook;Jay P. Ciezki;Ashley E. Ross

  • Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era ☆

    Deborah A Kuban;Howard D Thames;Larry B Levy;Eric M Horwitz

  • Long-Term Survival After Radical Prostatectomy Versus External Beam Radiotherapy for Patients with High-Risk Prostate Cancer

    Stephen A. Boorjian;R. Jeffrey Karnes;Rosalia Viterbo;Laureano J. Rangel

  • Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors.

    Di Yan;John Wong;Frank Vicini;Jeff Michalski

  • Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines

    James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Barry Boston

  • Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy

    Juanita M. Crook;Christopher J. O’Callaghan;Graeme Duncan;David P. Dearnaley

Frequent Co-Authors

Alan Pollack
Alan Pollack University of Miami
Robert G. Uzzo
Robert G. Uzzo Fox Chase Cancer Center
Alexandra L. Hanlon
Alexandra L. Hanlon Virginia Tech
Gerald E. Hanks
Gerald E. Hanks Fox Chase Cancer Center
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Patrick A. Kupelian
Patrick A. Kupelian University of California, Los Angeles
Jeff M. Michalski
Jeff M. Michalski Washington University in St. Louis
Alvaro Martinez
Alvaro Martinez Beaumont Health
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Michael J. Zelefsky
Michael J. Zelefsky Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional MD program in the USA isn’t the only pathway to enter the healthcare sector. Many students are now considering flexible and affordable options through online programs in related fields. For those interested in healthcare leadership and management, a healthcare administration degree online provides skills in policy, finance, and operations.

Students who want to advance further may look into an affordable mha online to open doors to executive and administrative roles. For nurses seeking clinical leadership, finding the cheapest dnp program online can be a cost-effective way to achieve the highest practice-focused nursing degree.

Likewise, aspiring pharmacists might explore a 3-year online pharmd program, allowing them to earn a doctorate in pharmacy with flexibility and affordability. These alternative online programs offer practical routes into high-demand healthcare careers while accommodating diverse learning needs and schedules.

Best Scientists Citing Eric M. Horwitz

Trending Scientists

Recently Published Articles